Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow

Immunological Reviews

Volumn 175, Issue , 2000, Pages 158-174

  Lu, Liwei ^a,b   Osmond, Dennis G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 7; MELATONIN; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNOGLOBULIN GENE; IMMUNOMODULATION; LYMPHOPOIESIS; MACROPHAGE; MALE; MOUSE; NEOPLASM; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN EXPRESSION; PROTO ONCOGENE; QUALITY CONTROL; STROMA CELL; TRANSGENE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD24; APOPTOSIS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; COLONY-STIMULATING FACTORS; DNA-BINDING PROTEINS; HOMEOSTASIS; INTERLEUKIN-7; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-ABL; RECEPTORS, ANTIGEN, B-CELL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033933693     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.017506.x     Document Type: Article

References (125)

1. 1. Osmond DG. B cell development in the bone marrow. Semin Immunol 1990;2:173-180.
2. 2. Osmond DG, et al. Apoptosis and macrophage mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow. Immunol Rev 1994;142:209-230.
3. 3. Osmond DG, Everett NB. Radioautographic studies of bone marrow lymphocytes in vivo and in diffusion chamber cultures. Blood 1964;23:1-17.
4. 4. Osmond DG, Everett NB. Nucleophagocytosis in bone marrow. Nature 1962;196:488-489.
5. 5. Osmond DG, Nossal GJV. Differentiation of lymphocytes in mouse bone marrow. II. Kinetics of maturation and renewal of antiglobulin-binding cells studied by double labeling. Cell Immunol 1974;13:132-145.
6. 6. Opstelten D, Osmond DG. Pre-B cells in mouse bone marrow: immunofluorescence stathmokinetic studies of the proliferation of cytoplasmic μ-chain-bearing cells in normal mice. J Immunol 1983;131:2635-2640.
7. 7. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
8. 8. Hale AJ, et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996;236:1-26.
9. 9. Scaffidi C, Kirchhoff S, Krammer PH, Peter ME. Apoptosis signaling in lymphocytes. Curr Opin Immunol 1999;11:277-285.
10. 10. Lu L, Osmond DG. Apoptosis during B lymphopoiesis in mouse bone marrow. J Immunol 1997;158:5136-5145.
11. 125I anti-IgM antibody. Am J Anat 1984;170:349-365.
12. + cells during postirradiation regeneration. Exp Hematol 1990;18:304-310.
13. 13. Jacobsen K, Osmond DG. Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow. Eur J Immunol 1990;20:2395-2404.
14. 14. Jacobsen K, Osmond DG. Cell deletion in B cell genesis and the role of bone marrow macrophages. In: Ezine S, Berrih-Aknin S, Imhof B, eds. Lymphatic tissues and in vivo immune responses. New York: Marcel Dekker; 1991. p. 343-354.
15. 15. Osmond DG. The turnover of B-cell populations. Immunol Today 1993;14:34-37.
16. 16. Jacobsen KA, Prasad VS, Sidman CL, Osmond DG. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of Eμ-myc transgenic mice. Blood 1994;84:2784-2794.
17. 17. Osmond DG. Production and selection of B lymphocytes in bone marrow: lymphostromal interactions and apoptosis in normal, mutant, and transgenic mice. In: Heinen E, et al. eds. In vivo immunology. New York: Plenum Press; 1994. p. 15-19.
18. 18. Park YH, Osmond DG. Phenotype and proliferation of early B lymphocyte precursor cells in mouse bone marrow. J Exp Med 1987;165:444-458.
19. 19. Osmond DG, Park YH. B lymphocyte progenitors in mouse bone marrow. Int Rev Immunol 1987;2:241-261.
20. 20. Park YH, Osmond DG. Dynamics of early B lymphocyte precursor cells in mouse bone marrow: proliferation of cells containing terminal deoxynucleotidyl transferase. Eur J Immunol 1989;19:2139-2144.
21. 21. Osmond DG. Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs. Curr Opin Immunol 1991;3:179-185.
22. 22. Osmond DG, Rolink A, Melchers F. Murine B lymphopoiesis: towards a unified model. Immunol Today 1998;19:65-68.
23. 23. Lu L, Smithson G, Kincade PW, Osmond DG. Two models of murine B lymphopoiesis: a correlation. Eur J Immunol 1998;28:1755-1761.
24. 24. Desiderio SV, et al. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 1984;311:752-755.
25. 25. Wasserman R, Li YS, Hardy RR. Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. J Immunol 1997;158:1133-1138.
26. 26. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991;173:1213-1225.
27. 27. Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993;5:207-217.
28. 28. Tudor KS, Payne KJ, Yamashita Y, Kincade PW. Functional assessment of precursors from murine bone marrow suggests a sequence of early B-lineage differentation events. Immunity 2000;12:335-345.
29. 29. Rico-Vargas SA, Weiskopf B, Nishikawa S, Osmond DG. c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody. J Immunol 1994;152:2845-2852.
30. 30. Rolink A, Grawunder U, Winkler TH, Karasuyama H, Melchers F. IL-2 receptor α-chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol 1994;6:1257-1264.
31. + cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med 1996;183:187-194.
32. 32. Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 1996;5:527-535.
33. 33. Karasuyama H, Rolink A, Shinkai Y, Young F, Alt FW, Melchers F. The expression of Vpre-B/λ-5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 1994;77:133-143.
34. 34. Winkler TH, Rolink A, Melchers F, Karasuyama H. Precursor B cells of mouse bone marrow express two different complexes with the surrogate light chain on the surface. Eur J Immunol 1995;25:446-450.
35. 35. Melchers F, et al. Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol 1995;7:214-227.
36. 36. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 1994;172:1-16.
37. 37. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
38. 38. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K. A critical role of λ 5 protein in B cell development. Cell 1992;69:823-831.
39. 39. Shinkai Y, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-867.
40. 40. Ehlich A, Martin V, Muller W, Rajewsky K. Analysis of the B-cell progenitor compartment at the level of single cells. Curr Biol 1994;4:573-583.
41. 41. Melchers F, et al. Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol 1995;7:214-2127.
42. 42. Fulop G, Gordon J, Osmond DG. Regulation of lymphocyte production in the bone marrow. I. Turnover of small lymphocytes in mice depleted of B lymphocytes by treatment with anti-IgM antibodies. J Immunol 1983;130:644-648.
43. 43. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
44. 44. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562-566.
45. 45. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-758.
46. 46. Lu L, Chaudhury P, Osmond DG. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2. J Immunol 1999;162:1931-1940.
47. 47. Lu L, Lejtenyi D, Osmond DG. Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow. Eur J Immunol 1999;29:2484-2490.
48. 48. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 1995;10:2263-2270.
49. 49. Guillouf C, et al. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 1995;85:2691-2698.
50. 50. Fukasawa K, Wiener F, Vande Woude GF, Mai S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 1997;15:1295-1302.
51. 51. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 1996;10:2038-2054.
52. 52. Osmond DG, Kim N, Manoukian R, Phillips RA, Rico-Vargas SA, Jacobsen K. Dynamics and localization of early B-lymphocyte precursor cells (pro-B cells) in the bone marrow of scid mice. Blood 1992;79:1695-1703.
53. 53. Blunt T, et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995;80:813-823.
54. 54. Namen AE, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988;333:571-573.
55. 55. Kincade PW. B lymphopoiesis: global factors, local control. Proc Natl Acad Sci USA 1994;91:2888-2889.
56. 56. Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, Durum SK. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999;10:41-60.
57. 57. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
58. 58. Grabstein KH, et al. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993;178:257-264.
59. 59. Morrissey PJ, et al. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J Immunol 1991;147:561-568.
60. 60. Valenzona HO, Dhanoa S, Finkelman FD, Osmond DG. Exogenous interleukin 7 as a proliferative stimulant of early precursor B cells in mouse bone marrow: efficacy of IL-7 injection, IL-7 infusion and IL-7-anti-IL-7 antibody complexes. Cytokine 1998;10:404-412.
61. 61. Fisher AG, Burdet C, Bunce C, Merkenschlager M, Ceredig R. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential. Int Immunol 1995;7:415-423.
62. 62. Valenzona HO, Pointer R, Ceredig R, Osmond DG. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol 1996;24:1521-1529.
63. 63. Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ, Venkitaraman AR. The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J 1996;15:1924-1932.
64. 64. Corcoran AE, Riddell A, Krooshoop D, Venkitaraman AR. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 1998;391:904-907.
65. 65. Hernandez-Caselles T, Martinez-Esparza M, Sancho D, Rubio G, Aparicio P. Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticosteroids and regulates bcl-2 and CD25 expression. Hum Immunol 1995;43:181-189.
66. 66. Candeias S, Muegge K, Durum SK. IL-7 receptor and VDJ recombination: trophic versus mechanistic actions. Immunity 1997;6:501-508.
67. 67. Griffiths SD, et al. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 1994;179:1789-1797.
68. 68. Alterman LA, Crispe IN, Kinnon C. Characterization of the murine heat-stable antigen: an hematolymphoid differentiation antigen defined by the J11d, M1/69 and B2A2 antibodies. Eur J Immunol 1990;20:1597-1602.
69. 69. Allman DM, Ferguson SE, Lentz VM, Cancro MP. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol 1993;151:4431-4444.
70. 70. Hough MR, Chappel MS, Sauvageau G, Takei F, Kay R, Humphries RK. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen. J Immunol 1996;156:479-488.
71. 71. Chappel MS, Hough MR, Mittel A, Takei F, Kay R, Humphries RK. Cross-linking the murine heat-stable antigen induces apoptosis in B cell precursors and suppresses the anti-CD40-induced proliferation of mature resting B lymphocytes. J Exp Med 1996;184:1638-1649.
72. 72. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K. A critical role of λ 5 protein in B cell development. Cell 1992;69:823-831.
73. 73. Kline GH, et al. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional μ heavy chains. J Immunol 1998;161:1608-1618.
74. 74. Nielsen PJ, et al. Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood 1997;89:1058-1067.
75. 75. Rosenberg N. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation. Semin Cancer Biol 1994;5:95-102.
76. 76. Laneuville P. Abl tyrosine protein kinase. Semin Immunol 1995;7:255-266.
77. 77. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature 1990;344:251-253.
78. 78. Griffiths SD, et al. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice. Oncogene 1992;7:1391-1399.
79. 79. Voncken JW, et al. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice. Blood 1992;79:1029-1036.
80. 80. Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J. Restricted oncogenicity of BCR/ABL p190 in transgenic mice. Cancer Res 1992;52:4534-4539.
81. 81. Dorsch M, Goff SP. Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. Proc Natl Acad Sci USA 1996;93:13131-13136.
82. 82. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E. BCR-ABL delays apoptosis upstream of procaspase-3 activation. Blood 1998;91:2415-2422.
83. 83. Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. Oncogene 1998;16:1383-1390.
84. 84. Amarante-Mendes GP, et al. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 1998;91:1700-1705.
85. 85. Wiktor-Jedrzejczak W, Gordon S. Cytokine regulation of the macrophage (Mφ) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev 1996;76:927-947.
86. 86. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983;21:151-159.
87. 87. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987;236:1229-1237.
88. 88. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997;89:1021-1031.
89. 89. Guilbert LJ, Stanley ER. Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells. J Cell Biol 1980;85:153-159.
90. 90. Yoshida H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444.
91. 91. Wiktor-Jedrzejczak W, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990;87:4828-4832.
92. 92. Kodama H, et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 1991;173:269-272.
93. 93. Wiktor-Jedrzejczak WW, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med 1982;156:1516-1527.
94. 94. Nelson RJ, Demas GE. Seasonal changes in immune function. Q Rev Biol 1996;71:511-548.
95. 95. Mazzoccoli G, et al. Age related changes of neuro-endocrine immune interactions in healthy humans. J Biol Regul Homeost Agents 1997;11:143-147.
96. 96. Calvo JR, Rafii el-Idrissi M, Pozo D, Guerrero JM. Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells. J Pineal Res 1995;18:119-126.
97. 97. Pozo D, et al. Expression of the Mel 1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J 1997;11:466-473.
98. 98. Sainz RM, et al. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res 1995;19:178-188.
99. 99. Maestroni GJ, Conti A. Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlates. Neuroimmunomodulation 1996;3:325-332.
100. 100. Provinciali M, Di Stefano G, Bulian D, Tibaldi A, Fabris N. Effect of melatonin and pineal grafting on thymocyte apoptosis in aging mice. Mech Ageing Dev 1996;90:1-19.
101. 101. Liebmann PM, Wolfler A, Felsner P, Hofer D, Schauenstein K. Melatonin and the immune system. Int Arch Allergy Immunol 1997;112:203-211.
102. 102. Yu Q, Miller SC, Osmond DG. Melatonin inhibits apoptosis during early B cell development in mouse bone marrow. J Pineal Res (In press).
103. 103. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-543.
104. 104. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996;88:386-401.
105. 105. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-776.
106. 106. Janani R, Harris AW, Strasser A, Dhanoa S, Plyam R, Osmond DG. Effect of a bcl-2 transgene on production and localization of precursor B cells in mouse bone marrow. Exp Hematol 1998;26:982-990.
107. 107. Miyashita T, et al. Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
108. 108. Kadmon G, Eckert M, Sammar M, Schachner M, Altevogt P. Nectadrin, the heat-stable antigen, is a cell adhesion molecule. J Cell Biol 1992;118:1245-1258.
109. 109. Hahne M, Wenger RH, Vestweber D, Nielsen PJ. The heat-stable antigen can alter very late antigen 4-mediated adhesion. J Exp Med 1994;179:1391-1395.
110. 110. Hubbe M, Altevogt P. Heat-stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function. Eur J Immunol 1994;24:731-737.
111. 111. Maestroni GJ, Hertens E, Galli P, Conti A, Pedrinis E. Melatonin-indticed T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin. J Pineal Res 1996;21:131-139.
112. 112. Boranic M, Krizanac-Bengez L, Gabrilovac J, Marotti T, Breljak D. Enkephalins in hematopoiesis. Biomed Pharmacother 1997;51:29-37.
113. 113. Maestroni GJ. κ-Opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin induced opioid cytokines. Ann N Y Acad Sci 1998;840:411-419.
114. 114. Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 1994;91:5382-5386.
115. 115. Fauteux LJ, Osmond DG. IL-1 as a systemic modifier of B lymphopoiesis: recombinant IL-1 α binds to stromal cells and sinusoid endothelium in bone marrow and perturbs precursor B cell dynamics. J Immunol 1996;156:2376-2383.
116. 116. Pietrangeli CE, Osmond DG. Regulation of B-lymphocyte production in the bone marrow: mediation of the effects of exogenous stimulants by adoptively transferred spleen cells. Cell Immunol 1987;107:348-357.
117. 117. Park YH, Osmond DG. Regulation of early precursor B cell proliferation in mouse bone marrow: stimulation by exogenous agents mediated by macrophages, in the spleen. Cell Immunol 1991;135:168-183.
118. 118. Rico-Vargas SA, Potter M, Osmond DG. Perturbation of B cell genesis in the bone marrow of pristane-treated mice: implications for plasmacytoma induction. J Immunol 1995;154:2082-2091.
119. 119. Mertsching E, Grawunder U, Meyer V, Rolink T, Ceredig R. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur J Immunol 1996;26:28-33.
120. 120. Jacks T, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
121. 121. Nacht M, et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 1996;10:2055-2066.
122. 122. Gotoh A, Broxmeyer HE. The function of BCR/ABL and related proto-oncogenes. Curr Opin Hematol 1997;4:3-11.
123. 113. Tchirkov A, et al. Molecular detection of a late-appearing BCR-ABL gene in a child with T-cell acute lymphoblastic leukemia. Ann Hematol 1998;77:55-59.
124. 124. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229:1390-1393.
125. 125. Bertoli LF, et al. Bone marrow origin of a B cell lymphoma. Blood 1988;72:94-101.